Last Updated : Thursday, November 14, 2019 20:40:01

Tag Archives: Oncology

NATCO Pharma’s Vishakhapatnam Formulation facility kicks-off

HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Hyderabad headquartered NATCO Pharma Ltd said of having commenced commercial manufacturing operations at company’s Vishakhapatnam formulation facility. In a press-release as submitted by the company to the Indian Bourses, titled – “Commercial Manufacturing Operations begin in NATCO’s

Dr. REDDY’S LAB enters Nutrition Segment with CELEVIDA in India

HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Hyderabad headquartered Dr. Reddy’s Laboratories said of having entered in Nutrition segment, where the company launched diabetes nutrition drink ‘Celevida’, in India. The press-release as submitted by the company to the Indian Bourses – titled, “Dr. Reddy’s

Stride Pharma forms JV with Sihuan Pharma, to enter China market

BENGALURU | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a press release submitted to the Indian Stock Exchanges, Bengaluru based Indian Pharma major Strides Pharma Sciences Ltd said of having entered into Chinese Pharmaceutical market in a joint-venture with Sihuan Pharmaceutical Holdings Group Ltd. The press release titled, “Strides enters the large China pharmaceutical market

Biocon & Mylan to present final overall survival data of biosimilar for cancer

HERTFORDSHIRE (ENGLAND) | PITTSBURGH (US) | BENGALURU | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT  – In a press release submitted to the Exchanges in India on Thursday, Biocon Ltd said of Biocon and Mylan to Present Final Overall Survival Data for Ogivri™ (trastuzumab-dkst), a biosimilar to Herceptin4P, at the American Society of Clinical Oncology (ASCO) Annual

Apollo Hospitals enters Lucknow, pays 910 million rupees, to acquires 50% stake in 330 bed super-speciality hospital project

LUCKNOW | CHENNAI | MUMBAI | RAJKOT – Apollo Hospital Enterprise Ltd India’s first multi-speciality chain of hospitals today announced that the company has acquired a 50% stake paying 910 million (~91 crore) rupees, in Medics International Lifesciences Ltd., a 330 bedded super-speciality hospital in Lucknow. The Apollo Medics Super Speciality Hospital would strengthen Apollo

Do NOT follow this link or you will be banned from the site!